AMNOG
Evidence Graph
Ask
Cases
Sources
Explore / Assessment
Assessment
Brigatinib
Cancer
Modules
IQWiG assessments · G-BA decisions
Connections
2
Connected evidence
2 relations
owns document
1
Outgoing
Nutzenbewertung IQWiG
Document
has assessment · incoming
1
Incoming
Brigatinib (neues Anwendungsgebiet: NSCLC, ALK+, ALK-Inhibitor-naive Patienten)
Procedure